We are excited to share four presentations (three in collaboration) at the upcoming ISPOR 21st Annual Meeting between May 21st and May 25th 2016. Come visit us at booth 32! Topics include economic impact of intravenous fluid choices for cardiac surgery, economic impact of in-home non-invasive ventilation for chronic obstructive pulmonary disease (COPD), impact of COPD comorbidities on readmissions, and postherpetic neuralgia treatment. Our results are supported by detailed analyses of EHR database which contains information about 60 million unique patients over a 15 year timeframe. More information on this database can be found here.
Please check out our events section for the full list of presentation titles and timetable.
To schedule a meeting with our team, please email us at info@bostonsp.com. We look forward to discussing ideas and insights on health economics and outcomes research and ways to support your business and clinical needs.
About ISPOR
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes).
(Source: http://www.ispor.org/about-ispor.asp)